Hans W. Nijman

23.0k total citations · 6 hit papers
204 papers, 13.4k citations indexed

About

Hans W. Nijman is a scholar working on Immunology, Oncology and Obstetrics and Gynecology. According to data from OpenAlex, Hans W. Nijman has authored 204 papers receiving a total of 13.4k indexed citations (citations by other indexed papers that have themselves been cited), including 90 papers in Immunology, 78 papers in Oncology and 73 papers in Obstetrics and Gynecology. Recurrent topics in Hans W. Nijman's work include Endometrial and Cervical Cancer Treatments (72 papers), Immunotherapy and Immune Responses (66 papers) and Ovarian cancer diagnosis and treatment (47 papers). Hans W. Nijman is often cited by papers focused on Endometrial and Cervical Cancer Treatments (72 papers), Immunotherapy and Immune Responses (66 papers) and Ovarian cancer diagnosis and treatment (47 papers). Hans W. Nijman collaborates with scholars based in Netherlands, United States and United Kingdom. Hans W. Nijman's co-authors include Toos Daemen, Cornelis J.M. Melief, Hans J. Geuze, Willem Stoorvogel, Clifford V. Harding, Graça Raposo, Ninke Leffers, Marco de Bruyn, Marloes J.M. Gooden and Geertruida H. de Bock and has published in prestigious journals such as Proceedings of the National Academy of Sciences, The Journal of Experimental Medicine and Journal of Clinical Oncology.

In The Last Decade

Hans W. Nijman

196 papers receiving 13.2k citations

Hit Papers

5 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

B lymphocytes secrete antigen-presenting vesicles.

1996 2.8k citations Hans W. Nijman, Cornelis J.M. Melief et al. profile →
The prognostic influence of tumour-infiltrating lymphocytes in cancer: a systematic review with meta-analysis

2011 994 citations Toos Daemen, Hans W. Nijman et al. British Journal of Cancer profile →
Tumor-infiltrating lymphocytes in the immunotherapy era

2020 584 citations Sterre T. Paijens, Annegé Vledder et al. profile →
Improved Risk Assessment by Integrating Molecular and Clinicopathological Factors in Early-stage Endometrial Cancer—Combined Analysis of the PORTEC Cohorts

2016 569 citations Ellen Stelloo, Remi A. Nout et al. Clinical Cancer Research profile →
Refining prognosis and identifying targetable pathways for high-risk endometrial cancer; a TransPORTEC initiative

2015 341 citations Ellen Stelloo, Tjalling Bosse et al. profile →
Tumour-infiltrating lymphocytes: from prognosis to treatment selection

2022 137 citations Marco de Bruyn, Hans W. Nijman et al. British Journal of Cancer profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Hans W. Nijman Netherlands	52	5.6k	4.8k	4.6k	3.0k	2.5k	204	13.4k
Alessandro D. Santin United States	53	2.4k 0.4×	4.6k 1.0×	3.2k 0.7×	2.0k 0.6×	1.4k 0.6×	353	10.6k
Masaki Mandai Japan	49	3.6k 0.6×	4.6k 1.0×	2.9k 0.6×	1.8k 0.6×	1.2k 0.5×	354	10.7k
Gemma G. Kenter Netherlands	64	5.0k 0.9×	5.2k 1.1×	2.5k 0.5×	3.6k 1.2×	1.3k 0.5×	234	14.4k
Gert Jan Fleuren Netherlands	61	5.8k 1.0×	4.8k 1.0×	3.5k 0.8×	934 0.3×	1.4k 0.6×	234	12.6k
Ronald D. Alvarez United States	63	1.6k 0.3×	4.3k 0.9×	4.6k 1.0×	2.7k 0.9×	779 0.3×	340	12.5k
Wen‐Fang Cheng Taiwan	50	2.2k 0.4×	1.7k 0.4×	3.2k 0.7×	1.1k 0.3×	1.6k 0.7×	291	8.1k
Takayuki Enomoto Japan	52	1.1k 0.2×	2.6k 0.5×	2.6k 0.6×	2.6k 0.8×	1.5k 0.6×	369	9.1k
Ate G.J. van der Zee Netherlands	49	1.3k 0.2×	2.2k 0.5×	2.9k 0.6×	2.2k 0.7×	1.3k 0.5×	142	9.3k
Peter Kenemans Netherlands	56	2.2k 0.4×	2.4k 0.5×	2.6k 0.6×	1.5k 0.5×	780 0.3×	304	11.6k
Leon F.A.G. Massuger Netherlands	59	1.1k 0.2×	2.8k 0.6×	2.3k 0.5×	2.5k 0.8×	1.1k 0.4×	360	12.8k

Countries citing papers authored by Hans W. Nijman

Since Specialization

Citations

This map shows the geographic impact of Hans W. Nijman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hans W. Nijman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hans W. Nijman more than expected).

Fields of papers citing papers by Hans W. Nijman

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hans W. Nijman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hans W. Nijman. The network helps show where Hans W. Nijman may publish in the future.

Co-authorship network of co-authors of Hans W. Nijman

This figure shows the co-authorship network connecting the top 25 collaborators of Hans W. Nijman. A scholar is included among the top collaborators of Hans W. Nijman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hans W. Nijman. Hans W. Nijman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Hami, Nizar, Hans W. Nijman, Jurgen M.J. Piek, et al.. (2025). The Prognostic Value of FOXL2 Mutant Circulating Tumor DNA in Adult Granulosa Cell Tumor Patients. Cancers. 17(11). 1894–1894.

Vledder, Annegé, Sterre T. Paijens, Annechien Plat, et al.. (2025). IL-6R expression is an independent prognostic factor in high-grade serous ovarian cancer. PubMed. 3(1). 49–49.

Nijman, Hans W., et al.. (2024). ImmunoPET provides a novel way to visualize the CD103+ tissue-resident memory T cell to predict the response of immune checkpoint inhibitors. EJNMMI Research. 14(1). 5–5.

Wenzel, Hans H.B., Jacobus van der Velden, Anje M. Spijkerboer, et al.. (2024). Diagnostic accuracy of MRI, CT, and [18F]FDG-PET-CT in detecting lymph node metastases in clinically early-stage cervical cancer — a nationwide Dutch cohort study. Insights into Imaging. 15(1). 36–36. 9 indexed citations

Wenzel, Hans H.B., Marissa C. van Maaren, Jacobus van der Velden, et al.. (2024). Radical hysterectomy or chemoradiotherapy for clinically early-stage cervical cancer with suspicious lymph nodes on imaging: a retrospective cohort study. Journal of Gynecologic Oncology. 36(2). e16–e16.

Kroon, Cor D. de, et al.. (2023). Incidence of gynaecological cancer during the COVID-19 pandemic: A population-based study in the Netherlands. Cancer Epidemiology. 85. 102405–102405. 2 indexed citations

Vermij, Lisa, Jan J. Jobsen, Mariël Brinkhuis, et al.. (2022). 2022-RA-568-ESGO Prognostic Relevance of FIGO grading is Limited to NSMP Endometrial Cancers. International Journal of Gynecological Cancer. 32. A97–A98. 1 indexed citations

Boer, Stephanie M. de, Melanie Powell, Alexandra Léary, et al.. (2022). 2022-RA-825-ESGO The impact of age on prognosis in women with endometrial cancer: a pooled analysis of the PORTEC-1, -2 and -3 randomised trials. International Journal of Gynecological Cancer. 32. A113–A113. 1 indexed citations

Vledder, Annegé, et al.. (2022). Rapid and efficient generation of antigen‐specific isogenic T cells from cryopreserved blood samples. Immunology and Cell Biology. 100(4). 285–295. 1 indexed citations

10.

Lubbers, Joyce M., Nienke van Rooij, Arjan Kol, et al.. (2022). Expression of CD39 Identifies Activated Intratumoral CD8+ T Cells in Mismatch Repair Deficient Endometrial Cancer. Cancers. 14(8). 1924–1924. 4 indexed citations

11.

Bruyn, Marco de, et al.. (2022). Tumour-infiltrating lymphocytes: from prognosis to treatment selection. British Journal of Cancer. 128(3). 451–458. 137 indexed citations breakdown →

12.

Wortman, Bastiaan G., Carien L. Creutzberg, Hein Putter, et al.. (2018). Ten-year results of the PORTEC-2 trial for high-intermediate risk endometrial carcinoma: improving patient selection for adjuvant therapy. British Journal of Cancer. 119(9). 1067–1074. 163 indexed citations

13.

Ezendam, Nicole P. M., Florine A. Eggink, Dennis van Hamont, et al.. (2018). Implementation of laparoscopic hysterectomy for endometrial cancer over the past decade. Gynecological Surgery. 15(1). 7–7. 5 indexed citations

14.

Wall, Stephanie van de, Karl Ljungberg, Annemarie Boerma, et al.. (2018). Potent therapeutic efficacy of an alphavirus replicon DNA vaccine expressing human papilloma virus E6 and E7 antigens. OncoImmunology. 7(10). e1487913–e1487913. 33 indexed citations

15.

Stelloo, Ellen, Remi A. Nout, Elisabeth M. Osse, et al.. (2016). Improved Risk Assessment by Integrating Molecular and Clinicopathological Factors in Early-stage Endometrial Cancer—Combined Analysis of the PORTEC Cohorts. Clinical Cancer Research. 22(16). 4215–4224. 569 indexed citations breakdown →

16.

Wouters, Maartje C.A., Fenne L. Komdeur, Hagma H. Workel, et al.. (2015). Treatment Regimen, Surgical Outcome, and T-cell Differentiation Influence Prognostic Benefit of Tumor-Infiltrating Lymphocytes in High-Grade Serous Ovarian Cancer. Clinical Cancer Research. 22(3). 714–724. 56 indexed citations

17.

Gool, Inge C. van, Florine A. Eggink, Luke Freeman-Mills, et al.. (2015). POLE Proofreading Mutations Elicit an Antitumor Immune Response in Endometrial Cancer. Clinical Cancer Research. 21(14). 3347–3355. 231 indexed citations

18.

Jong, Renske A. de, Elisabeth Pras, H. Marike Boezen, et al.. (2012). Less Gastrointestinal Toxicity After Adjuvant Radiotherapy on a Small Pelvic Field Compared to a Standard Pelvic Field in Patients With Endometrial Carcinoma. International Journal of Gynecological Cancer. 22(7). 1177–1186. 7 indexed citations

19.

Nijhuis, Esther R., Nathalie Reesink‐Peters, G. Bea A. Wisman, et al.. (2006). An Overview of Innovative Techniques to Improve Cervical Cancer Screening. Analytical Cellular Pathology. 28(5-6). 233–246. 14 indexed citations

20.

Nijman, Hans W., Peter Kenemans, Rob A. Verstraeten, et al.. (1999). Influence of chemotherapy on the expression of p53, HER-2/neu and proliferation markers in ovarian cancer. European Journal of Obstetrics & Gynecology and Reproductive Biology. 83(2). 201–206. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact